despit
recent
advanc
understand
infect
major
scientif
mysteri
remain
infect
still
global
challeng
mankind
virus
exclus
depend
host
cellular
machineri
propag
surviv
therefor
need
invad
host
cell
genom
entri
target
cell
involv
envelop
sever
major
step
infect
bind
cellsurfac
receptor
coreceptor
subsequ
bind
suffici
entri
host
cell
membran
fuse
membran
fusogen
result
activ
virushost
cell
interact
process
induc
conform
chang
within
viral
envelop
protein
structur
rearrang
within
allow
bind
coreceptor
chemokinereceptor
famili
aid
viru
entri
use
two
import
coreceptor
chemokin
receptor
coreceptor
util
macrophag
mtropic
virus
refer
virus
chemokin
receptor
coreceptor
ttropic
virus
especi
use
virus
appear
later
infect
dualtrop
strain
use
coreceptor
strain
trigger
fusion
requir
cleavag
two
nine
disulfid
bond
cellsurfac
protein
disulfideisomeras
pdi
activ
fusogen
result
precis
thioldisulfid
rearrang
mediat
either
endogen
redox
autocatalyt
isomeras
cellassoci
oxidoreductas
addit
thioldisulfid
exchang
envelop
protein
prerequisit
envelopemedi
tcell
fusion
inhibit
contact
envelop
protein
receptor
coreceptor
might
therefor
import
target
bodi
defenc
innat
immun
system
first
line
defenc
invad
pathogen
entri
host
initi
immedi
respons
control
viru
propag
neutrophil
recruit
site
viral
infect
act
first
line
defenc
myeloperoxidas
mpo
heme
enzym
releas
azurophil
intracellular
granul
activ
neutrophil
abund
protein
neutrophil
physiolog
concentr
chlorid
like
substrat
hypochlor
acid
hocl
shown
major
endproduct
pka
valu
hocl
thu
physiolog
ph
approxim
equal
concentr
hocl
present
use
term
hocl
describ
mixtur
klebanoff
colleagu
show
alreadi
begin
myeloperoxidasehocl
system
polymorphonuclear
leukocyt
mononuclear
phagocyt
virucid
effect
vitro
heme
enzym
myeloperoxidas
effici
stop
propag
hocl
react
kill
microb
directli
myeloperoxidas
releas
outsid
cell
attack
normal
tissu
segal
found
major
protein
get
oxidis
myeloperoxidas
hypohalid
system
surprisingli
belong
host
invad
plasma
protein
consum
major
hocl
hoclmedi
oxid
major
plasma
protein
albumin
investig
pattison
et
al
doubt
myeloperoxidas
system
capabl
inactiv
directli
may
addit
indirect
mode
action
protein
amino
acid
highli
abund
vivo
react
rapidli
hocl
like
major
target
hocl
exposur
protein
hocl
result
loss
protein
structur
unfold
find
hoclalt
protein
name
immun
defencealteredprotein
ideap
amyloidlik
bound
high
affin
protein
offer
free
shgroup
recent
publish
knowledg
amyloidlik
semenderiv
enhanc
viral
infect
sevi
role
thiol
entri
prompt
us
studi
whether
ideap
abl
inhibit
infect
investig
consequ
protein
modif
myeloperoxidasehocl
immun
defenc
system
pool
plasma
protein
isol
human
plasma
modifi
hocl
gener
ideapp
subsequ
test
capac
bind
receptor
pdi
control
unalt
pool
plasma
protein
pp
use
bind
studi
elisa
assay
show
specif
bind
well
pdi
ideapp
wherea
bind
nonmodifi
origin
materi
signific
fig
b
bind
nonmodifi
origin
materi
pdi
observ
bind
hoclalt
materi
significantli
higher
bind
confirm
surfac
plasmon
reson
spr
spectrometri
spr
demonstr
immobil
well
pdi
bind
ideapp
high
affin
fig
e
f
sensorgram
could
fit
langmuir
model
use
biaevalu
softwar
ge
healthcar
gain
quantit
data
offrat
slow
reliabl
estim
method
associ
phase
biacor
experi
also
affect
dissoci
rate
inher
fit
method
addit
assumpt
associ
dissoci
rate
true
onetoon
interact
model
ideapp
mixtur
protein
sever
oligomer
presum
present
sever
bind
site
model
use
therefor
reliabl
quantit
data
given
control
experi
use
unmodifi
plasma
protein
respons
unit
ru
spr
thu
ideapp
repres
put
therapeut
agent
interfer
viral
bind
fusion
host
cell
order
studi
effect
ideapp
viral
bind
fusion
human
cell
pool
plasma
protein
pp
alter
ideapp
use
differ
molar
ratio
protein
hocl
ratio
use
experi
evalu
optim
procedur
neither
ideapp
control
pp
toxic
human
cell
use
concentr
sinc
mitochondri
activ
decreas
fig
b
first
assay
test
effect
ideapp
bind
fusion
human
cell
base
adher
hela
cell
line
stabli
transfect
episom
vector
carri
gene
control
long
termin
repeat
ltr
promot
infect
cell
transactiv
ltr
promot
induc
product
infect
cell
stain
dark
blue
addit
chromogen
substrat
xgal
test
ideapp
pool
reduc
number
cell
dose
depend
manner
fig
e
f
wherea
nonmodifi
origin
materi
effect
fig
howev
antivir
effect
promin
ideapp
produc
molar
ratio
protein
hocl
fig
compar
materi
gener
ratio
fig
higher
ratio
increas
virusinhibitori
effect
ideapp
fig
light
microscopi
visual
nearli
host
cell
treat
control
pool
plasma
protein
pp
stain
intens
blue
show
infect
iiib
fig
upper
row
sporad
host
cell
infect
iiib
viru
preincub
ideapp
fig
upper
row
iiib
capabl
induc
syncytia
format
infect
host
cell
infect
host
cell
fuse
togeth
induc
interact
plasma
membran
form
larg
giant
cell
sever
nuclei
inhibit
syncytia
format
ideapp
seen
use
cell
pool
plasma
protein
control
effect
fig
lower
row
pp
control
versu
fig
lower
row
ideapp
pool
plasma
protein
control
addit
influenc
format
syncytia
fig
particl
preincub
increas
concentr
pp
induc
less
syncytia
treat
medium
contrast
number
syncytia
decreas
viral
particl
incub
ideapp
gener
differ
molar
ratio
fig
e
g
seen
previou
experi
number
infect
host
cell
quantifi
ideapp
prepar
ratio
effect
interfer
syncytia
format
ideapp
prepar
ratio
fig
fig
higher
ratio
could
increas
inhibitori
effect
ideapp
viru
induc
syncytia
format
fig
measur
major
capsid
protein
antigen
cell
cultur
supernat
longestablish
method
viru
quantif
unmodifi
pool
plasma
protein
reduc
amount
cell
supernat
fig
ideapp
decreas
level
dosedepend
manner
fig
fig
fig
result
correspond
seen
number
syncytia
answer
question
whether
inhibit
strainspecif
repres
gener
phenomenon
test
capac
ideapp
inhibit
isol
iiib
infect
anoth
viral
strain
significantli
reduc
preincub
particl
ideapp
prepar
molar
ratio
fig
infect
clone
subtyp
f
primari
isol
brazilian
patient
inhibit
preincub
ideapp
prepar
molar
ratio
fig
c
dosedepend
manner
effect
ideapp
prepar
molar
ratio
less
promin
fig
control
pp
effect
fig
set
experi
evalu
purifi
plasma
protein
alter
hocl
capac
interfer
viral
infect
reason
chose
human
serum
albumin
hsa
promin
plasma
protein
antithrombin
iii
atiii
repres
plasma
protein
compar
antivir
effect
modifi
form
correspond
unmodifi
protein
inhibit
viral
infect
ideahsa
comparison
hsa
could
observ
reduct
infect
cell
fig
b
fig
upper
row
versu
fig
upper
row
fig
well
decreas
number
syncytia
fig
fig
lower
row
versu
fig
lower
row
fig
antivir
effect
ideahsa
limit
isol
iiib
sinc
dualtrop
primari
isol
also
inactiv
contact
ideahsa
fig
h
verifi
acquir
antivir
activ
modif
hocl
restrict
albumin
includ
modifi
antithrombin
iii
experi
preincub
increas
concentr
ideaatiii
infect
viru
highli
decreas
shown
reduc
number
infect
cell
lower
amount
syncytia
fig
fig
effect
visibl
viru
incub
unmodifi
atiii
fig
surfac
plasmon
reson
spr
use
monitor
interact
real
time
seen
alter
plasma
protein
mixtur
ideaatiii
show
also
highaffin
bind
fig
fig
pdi
fig
reliabl
rate
dissoci
rate
constant
kd
given
kd
depend
associ
dissoci
rate
compound
offrat
slow
meaning
determin
addit
antithrombin
iii
hsa
test
fibrinogen
coagul
factor
viii
bovin
serum
albumin
protein
success
transform
antivir
agent
alter
hocl
ideaprotein
use
studi
tend
oligomer
aggreg
contrast
unmodifi
protein
test
whether
partial
unfold
misfold
hocl
treatment
therefor
amyloidlik
coagul
factor
xii
fxii
tissu
plasminogen
activ
tpa
chaperon
bip
protein
capabl
bind
protein
amyloidlik
properti
bound
test
ideaprotein
ideapp
ideahsa
ideaatiii
figur
hocl
treatment
protein
induc
oligomeris
addit
previous
made
observ
ideap
bound
reduc
glutathion
gsh
clarifi
mechan
ideap
exert
antivir
activ
test
therefor
hypothesi
bind
ideap
pdi
respect
least
partial
thiolmedi
inhibitor
free
sulfhydryl
penetr
membran
dtnb
use
examin
role
ectosulfhydryl
interact
ideap
pdi
viral
envelop
protein
receptor
pdi
respect
preincub
increas
concentr
thiol
blocker
dtnb
bind
ideahsa
well
pdi
inhibit
dtnb
fig
b
c
addit
bind
ideapp
ideaatiii
hoclalt
protein
inhibit
direct
thiol
blocker
data
shown
hocltreat
protein
lead
format
aldehyd
react
lysin
group
form
shbind
form
lysin
fdplysin
group
therefor
test
whether
ideap
antivir
activ
contain
fdplysin
group
specif
monoclon
antibodi
fdplysin
bound
specif
dosedepend
ideap
prepar
fig
show
bind
anti
fdplysin
monoclon
antibodi
ideahsa
hsa
neutrophil
contribut
pathogen
clearanc
produc
neutrophil
extracellular
trap
net
akongmoor
et
al
recent
studi
net
format
found
exogen
addit
hocl
stimul
netosi
exogen
hocl
could
rescu
netosi
set
mpo
inhibit
myeloperoxidas
associ
neutrophil
extracellular
trap
activ
therefor
like
produc
ideap
recent
saitoh
et
al
show
net
addit
bacteria
fungi
also
captur
human
immunodefici
viru
ideaprotein
special
amyloidlik
protein
second
mode
action
interfer
mesh
built
chromatin
strand
amyloidlik
ideap
may
support
ideaprotein
bind
immobil
gsh
bind
ideaprotein
pdi
inhibit
dtnb
show
ideap
like
interact
ectosulfhydryl
pdi
treatment
plasma
protein
myeloperoxidasehocl
system
shown
lead
convers
lthreonin
dehydr
product
acrolein
extrem
reactiv
aldehyd
aldehyd
product
also
mimick
hypochlor
acid
hocl
absenc
enzym
murin
model
acut
myocardi
infarct
myeloperoxidasehocl
system
found
major
sourc
acrolein
aldehyd
acrolein
form
bisadduct
lysin
residu
call
fdplysin
electrophil
carbonyl
moieti
retain
fdplysin
allow
undergo
nucleophil
addit
thiol
proteinconjug
fdplysin
detect
fdplysin
specif
antibodi
use
antibodi
document
ideahsa
unmodifi
mother
protein
hsa
contain
fdplysin
residu
ideap
bind
pdi
inhibit
dtnb
ideap
clearli
contain
access
chemic
group
react
eagerli
free
sh
group
like
shgroup
least
part
involv
interact
ideap
fdplysin
group
shown
bind
coval
free
sh
group
protein
dehydrogenas
probabl
fdplysin
group
ideap
also
link
ideap
target
coval
manner
slow
rate
seen
sensorgram
plasmon
reson
data
support
interpret
conclus
postul
myeloperoxidasehocl
system
addit
role
host
defenc
work
mechan
form
entri
inhibitor
form
amyloidlik
protein
immobil
viru
gener
fdplysin
residu
protein
attack
ectosulfhydryl
pdi
fig
question
enough
ideap
combat
invas
might
answer
observ
signific
impair
neutrophil
function
advanc
infect
recent
observ
counteract
neutrophil
respons
addit
neutropenia
varieti
qualit
defect
neutrophil
function
describ
infect
microorgan
depend
amyloid
coat
attach
host
cell
activ
thiol
entri
host
cell
well
coxsackieviru
dengu
fever
viru
serotyp
use
amyloid
recogn
chaperon
bip
coreceptor
viru
intern
ryser
et
al
describ
entri
host
cell
inhibit
bacitracin
bacitracin
usual
consid
specif
inhibitor
pdi
activ
recent
howev
bacitracin
shown
addit
signific
effect
catalyz
protein
fold
molecular
chaperon
especi
bacitracin
significantli
inhibit
chaperon
activ
bip
gener
bind
protein
amyloidlik
protein
ideaprotein
bind
bip
known
entri
inhibitor
bacitracin
inhibit
bip
like
addit
chaperon
pdi
chaperon
princip
sensor
amyloidogen
protein
involv
involv
cell
surfac
bip
would
also
explain
enhanc
infect
semenderiv
enhanc
viru
infect
sevi
virus
shown
use
bip
internalis
ideaprotein
might
also
use
inhibitor
viru
infect
jain
et
al
observ
block
product
free
thiol
thioldisulfid
exchang
inhibitor
fusion
protein
f
newcastl
diseas
viru
ndv
f
protein
inhibit
membran
fusion
requir
viral
entri
cellcel
fusion
role
thioldisulfid
exchang
host
cell
entryinvas
restrict
virus
accord
conant
et
al
chlamydia
attach
mammalian
cell
requir
protein
disulfid
isomeras
disulfid
oxidoreductas
activ
shigella
flexneri
requir
invas
epitheli
cell
protein
disulfid
isomeras
parasit
neospora
canium
involv
tachyzoitehost
cell
interact
pdi
even
identifi
play
import
role
cancer
cell
glioma
invas
therefor
newli
discov
neutrophil
function
might
gener
relev
path
physiolog
ethic
approv
studi
obtain
innsbruck
medic
univers
austria
pbmc
separ
blood
donat
written
inform
consent
obtain
particip
anonym
blood
donor
central
institut
blood
transfus
immunolog
depart
innsbruck
austria
human
epitheliallik
cell
line
pbkltrlac
adher
cell
stabli
transfect
episom
vector
carri
escherichia
coli
gene
control
long
termin
repeat
ltr
promot
cell
line
purchas
programm
eva
centr
aid
reagent
hertfordshir
uk
cultur
dmem
medium
life
technolog
vienna
austria
supplement
fetal
calf
serum
fc
biowhittak
vervier
belgium
penicillinstreptomycin
uml
respect
mm
lglutamin
life
technolog
mgml
geneticin
select
antigen
sigma
hygromycin
b
select
pbkltrlac
episom
sigma
tlymphoblastoid
cell
line
cultiv
rpmi
medium
life
technolog
supplement
fc
penicillinstreptomycin
mm
lglutamin
strain
iiib
subtyp
b
mrc
grown
propag
cell
line
clone
subtyp
f
isol
brazilean
patient
propag
human
peripher
blood
mononuclear
cell
pbmc
isol
healthi
human
blood
donor
viral
strain
purchas
aid
research
refer
reagent
program
niaid
nih
viru
fulllength
replic
infect
compet
chimera
fragment
deriv
provir
fragment
provir
lav
viruscontain
cell
cultur
supernat
harvest
day
infect
filter
remov
cell
debri
viral
particl
purifi
ultracentrifug
g
h
pellet
resuspend
rpmi
medium
frozen
viral
yield
determin
antigen
elisa
develop
institut
appli
microbiolog
vienna
austria
assay
monoclon
antibodi
use
kind
gift
h
kating
institut
appli
microbiolog
briefli
micropl
coat
overnight
first
monoclon
antibodi
wash
three
time
serva
heidelberg
germani
dilut
seri
viral
stock
appli
plate
togeth
second
antibodi
conjug
biotin
h
plate
consequ
incub
roch
wien
austria
min
amount
bound
quantifi
ad
substrat
solut
sigma
st
loui
usa
measur
optic
densiti
nm
use
elisa
reader
assay
calibr
use
baculovirusderiv
recombin
standard
normal
purifi
human
protein
transform
antivir
form
ideap
ad
hocl
mimic
action
system
molar
ratio
given
result
alter
complex
plasma
protein
composit
estim
averag
molecular
weight
kd
protein
taken
basi
brief
freshli
prepar
hocl
ad
protein
phosphat
buffer
salt
solut
pb
ph
mixtur
incub
min
rt
remain
hocl
separ
gelfiltr
use
sephadex
column
ge
healthcar
transform
protein
mixtur
human
plasma
immun
defencealt
plasma
protein
ideapp
protein
precipit
human
plasma
ammonium
sulfat
dialys
remov
ammonium
sulfat
modifi
directli
freshli
prepar
hocl
examin
potenti
toxic
ideap
hela
cell
incub
increas
amount
substanc
mitochondri
activ
analyz
use
commerci
avail
test
kit
accord
manufactur
instruct
promega
madison
usa
day
mt
reagent
ad
cell
convers
activ
mitochondri
enzym
measur
elisaread
determin
optic
densiti
dual
wavelength
nm
nm
hela
cell
line
infect
differ
virus
concentr
ngml
purpos
viru
preincub
either
medium
differ
concentr
ideap
h
room
temperatur
mixtur
given
cell
h
follow
remov
cell
cultur
supernat
intens
wash
addit
fresh
medium
either
without
ideap
quantifi
viral
infect
propag
three
differ
test
appli
day
first
number
form
syncytia
per
well
quantifi
microscop
second
secret
progenitor
viru
cultur
supernat
examin
use
assay
describ
third
number
infect
cell
investig
addit
chromogen
substrat
xgal
sinc
viral
infect
transactiv
ltr
promot
induc
product
purpos
cell
wash
pb
follow
fix
glutaraldehyd
min
room
temperatur
afterward
solut
replac
pb
contain
xgal
mm
potassium
ferricyanid
mm
potassium
ferrocyanid
mm
ph
incub
h
blue
foci
count
microscop
cell
incub
ngml
viru
preincub
medium
without
ideap
describ
viral
infect
propag
quantifi
count
syncytia
microscop
full
length
glycosyl
recombin
lav
iiib
lav
recombin
purchas
protein
scienc
corpor
meriden
ct
usa
protein
disulfid
isomeras
pdi
takara
otsu
japan
bind
differ
ideap
iiib
well
pdi
demonstr
standard
elisa
brief
bottom
well
nunc
polystyren
well
elisa
plate
coat
pdi
respect
ngwell
coat
buffer
night
select
coat
block
buffer
mm
disodium
carbon
mm
sodium
hydrogen
carbon
buffer
ph
gelatin
solut
phosphatebuff
salin
solut
pbst
respect
well
block
h
rt
plate
wash
time
wash
buffer
pbst
per
well
residu
wash
buffer
remov
ideap
sampl
unalt
mother
protein
ad
appropri
well
incub
hour
plate
wash
thoroughli
antibodi
hsa
fibrinogen
antithrombin
iii
dako
hamburg
germani
ad
plate
wash
secondari
peroxidas
label
antibodi
ad
detect
primari
antibodi
concentr
recommend
manufactur
atb
substrat
given
well
plate
wrap
shield
light
incub
room
temperatur
absorb
read
experi
run
least
triplic
surfac
plasmon
reson
spr
biosensor
enabl
rapid
label
free
sens
biomolecular
interact
spr
phenomenon
occur
polar
light
condit
total
intern
reflect
strike
electr
conduct
gold
layer
biacor
biacor
system
biacor
ab
sweden
use
pdi
respect
immobil
sensor
chip
use
amin
coupl
kit
biacor
ab
condit
follow
run
buffer
mm
tri
mm
nacl
ph
mm
mm
surfact
coupl
buffer
mm
naac
ph
immobil
amount
immobil
amount
pdi
immobil
amount
ru
immobilis
free
amino
group
chip
surfac
quench
ethanolamin
bind
ideap
investig
exampl
ideap
experiment
procedur
ideaatiii
given
detail
ideaatiii
inject
three
differ
concentr
flow
rate
protein
solut
dilut
sampl
buffer
increas
ideaatiii
amount
result
signal
increas
overlap
sensorgram
show
bind
ideaatiii
immobil
pdi
subsequ
dissoci
creat
sensorgram
correct
subtract
signal
refer
flow
cell
nonalt
origin
protein
protein
mixtur
use
control
dithiobisnitrobenzo
acid
dtnb
sigma
taufkirchen
germani
per
well
mm
pb
ph
parachloromercuriphenyl
sulfon
pcmp
sigma
taufkirchen
germani
pb
ph
ad
immobil
immobil
immobil
pdi
well
elisapl
minut
unbound
thiolreag
wash
away
thoroughli
afterward
plate
process
describ
measur
bind
ideap
pdi
respect
maa
et
al
disclos
tpa
fxii
well
chaperon
bip
capabl
bind
protein
amyloid
modul
bind
ideapp
ideahsa
ideaatii
three
gener
amyloid
recogn
tool
studi
elisa
recombin
tpa
coagul
factor
fxii
purchas
boehring
ingelheim
ingelheim
germani
haemochrom
diagnostica
essen
germani
respect
recombin
human
bip
bioscienc
inc
victoria
canada
bind
differ
ideap
tpa
fxii
well
bip
demonstr
standard
elisa
brief
bottom
well
nunc
polystyren
well
elisa
plate
coat
tpa
fxii
bip
respect
ngwell
coat
buffer
night
select
coat
block
buffer
mm
disodium
carbon
mm
sodium
hydrogen
carbon
buffer
ph
gelatin
solut
phosphatebuff
salin
solut
pbst
respect
well
block
h
rt
plate
wash
time
wash
buffer
pbst
per
well
residu
wash
buffer
remov
ideapp
ideahsa
ideaatiii
sampl
unalt
mother
protein
ad
appropri
well
incub
hour
plate
wash
thoroughli
specif
antibodi
ad
plate
wash
secondari
peroxidas
label
antibodi
ad
detect
primari
antibodi
concentr
recommend
manufactur
atb
substrat
given
well
plate
wrap
shield
light
incub
room
temperatur
absorb
read
experi
run
least
triplic
